Qalsody
Ended Awarded
- Contract number
- 36C26024F0379
- Awardee
-
Biogen U.s. Corporation UEI E82LHNZSCUA3
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $43,477
Award facts
- Contract value 100% obligated
- $43,476.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Biogen U.S. Corporation, a pharmaceutical manufacturer, for the supply of QALSODY and QALSODY (TOFERSEN) 6.7MG SOLN. This $43,476.60 order was placed against Biogen's Pharmaceuticals and Drugs GSA Schedule contract and will be delivered by June 1, 2024. Biogen also holds a $11.39 million single-award indefinite delivery contract with the VA National Acquisition Center to provide ranibizumab vials and syringes, likely for treating eye conditions, as well as a $430,578.10 Blanket Purchase Agreement for Spinraza, a drug used to treat spinal muscular atrophy. These contract vehicles enable the VA to efficiently acquire necessary pharmaceuticals for veterans nationwide through December 2024. The contract award did not have a set-aside designation.
Quick answers
Who was awarded contract 36C26024F0379?
36C26024F0379 was awarded to Biogen U.s. Corporation by Veterans Integrated Service Network 20 (Veterans Health Administration) on April 24, 2024.
How much is contract 36C26024F0379 worth?
The government has obligated $43,477 on 36C26024F0379.
Is contract 36C26024F0379 an order under another contract?
Yes. 36C26024F0379 is a delivery order under 36F79718D0566, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0379 competed?
The extent of competition for 36C26024F0379 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award